Caprock Group, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caprock Group, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$269,000
-19.5%
4,6250.0%0.06%
-12.3%
Q4 2017$334,000
+45.9%
4,625
+6.0%
0.06%
+35.4%
Q3 2017$229,000
+7.5%
4,365
-4.3%
0.05%
+2.1%
Q2 2017$213,000
-6.2%
4,560
-0.7%
0.05%
-11.3%
Q1 2017$227,000
-13.0%
4,591
+6.7%
0.05%
-19.7%
Q4 2016$261,000
-10.6%
4,304
-2.2%
0.07%0.0%
Q3 2016$292,0004,4030.07%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders